8VF1
Crystal Structure of the Hendra Virus Attachment G glycoprotein (HeV-G)
Summary for 8VF1
| Entry DOI | 10.2210/pdb8vf1/pdb |
| Descriptor | Glycoprotein G, alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total) |
| Functional Keywords | attachment protein, viral protein |
| Biological source | Henipavirus hendraense |
| Total number of polymer chains | 2 |
| Total formula weight | 104406.51 |
| Authors | Ve, T.,von Itzstein, M.S.,Winger, M.,Malde, A.K.,Holt, S.,McAtamney, S.,Hartley-Tassell, L.,Maggioni, A.,von Itzstein, M. (deposition date: 2023-12-21, release date: 2025-03-19, Last modification date: 2025-10-22) |
| Primary citation | von Itzstein, M.S.,Winger, M.,Malde, A.K.,Holt, S.,McAtamney, S.,Hartley-Tassell, L.,Ve, T.,Maggioni, A.,von Itzstein, M. Nipah and Hendra Viruses Use an Adjustable Latch in Receptor Engagement. Acs Infect Dis., 11:2729-2738, 2025 Cited by PubMed Abstract: Nipah (NiV) and Hendra viruses (HeV) have emerged as deadly zoonotic pathogens over the last three decades. Like all paramyxoviruses, Henipaviruses utilize a surface glycoprotein to attach to and invade targeted cells. Inhibiting this attachment glycoprotein is a promising strategy for developing effective antihenipaviral drugs. A multidisciplinary approach has been employed to investigate the structures of HeV and NiV attachment glycoproteins, identifying a flexible region near their binding site. This region, loop 240, can adopt an open conformation in unliganded attachment glycoproteins and a closed "latch" conformation in the presence of their cognate receptor Ephrin B2. Site-directed mutagenesis of the HeV attachment glycoproteins has shown that the engagement of R242 with Ephrin B2 plays an important role in the binding mechanism. This discovery provides greater insight into the dynamic nature of henipaviral attachment proteins and has implications for antiviral drug development. PubMed: 41003672DOI: 10.1021/acsinfecdis.4c01040 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (3 Å) |
Structure validation
Download full validation report






